NCT05408637View on ClinicalTrials.gov

Transcranial Photobiomodulation for Executive Function in Bipolar Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

August 9, 2022

Primary Completion Date

May 14, 2024

Study Completion Date

May 14, 2024

Conditions
Bipolar Disorder
Interventions
DEVICE

Transcranial Phoobiomodulation (tPBM)

Transcranial light therapy penetrates the skin and brain using light energy; this makes transcranial light therapy noninvasive. Transcranial light therapy may activate under-stimulated brain regions.

Trial Locations (1)

02129

Mass General Hospital Navy Yard Building 149, Charlestown

All Listed Sponsors
lead

Paolo Cassano

OTHER